Acylated spiropiperidine derivatives as melanocortin-4...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 491/20 (2006.01) A61K 31/438 (2006.01) A61K 31/4545 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 15/10 (2006.01) C07D 471/10 (2006.01)

Patent

CA 2624030

Certain novel N-acylated spiropiperidine derivatives are ligands of the human melanocortin receptor(s) and, in particular, are selective ligands of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of MC-4R, such as obesity, diabetes, nicotine addiction, alcoholism, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.

Certains nouveaux dérivés spiropipéridines acylés sont des ligands des récepteurs humains de la mélanocortine-4 (MC-4R). Ils conviennent donc pour le traitement de, la lutte contre, et la prévention d'affections et de troubles réagissant à la modulation de MC-4R, et notamment l'obésité, le diabète, la dépendance nicotinique, l'alcoolisme et les difficultés sexuelles y-compris les troubles de l'érection chez l'homme et les troubles de l'excitation sexuelle chez la femme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Acylated spiropiperidine derivatives as melanocortin-4... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acylated spiropiperidine derivatives as melanocortin-4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated spiropiperidine derivatives as melanocortin-4... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1724698

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.